⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CLNN News
Clene Inc. Common Stock
Form 8-K
sec.gov
CLNN
Form 8-K
sec.gov
CLNN
Clene Announces New Drug Application Submission to FDA for CNM-Au8 for the Treatment of ALS
globenewswire.com
CLNN
Clene to Present at Upcoming Investor Conferences
globenewswire.com
CLNN
Clene Announces Closing of $4 Million Registered Direct Offering Extending Capital Runway Beyond FDA Decision on CNM-Au8® NDA
globenewswire.com
CLNN
Form 8-K
sec.gov
CLNN
Clene Announces $4 Million Registered Direct Offering
globenewswire.com
CLNN
A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach
globenewswire.com
QNTM
SNY
BIIB
CLNN
Clene to Present at Upcoming September Investor Conferences
globenewswire.com
CLNN
Oncolytic Virus Cancer Therapy Market Expected to Expand Rapidly During the Forecast Period (2026-2036) Amid Rising Investments in Next-Generation Cancer Treatments| DelveInsight
prnewswire.com
AMGN
CGON
CLNN
RPRX
BTAI
ONCY